CLVR - Clever Leaves Holdings Inc.
Clever Leaves Holdings Inc.
Bodega 19B, Parque Industrial Tibitoc
TocancipA
Tocancipá
Colombia
https://cleverleaves.com
Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full-time employees: 400
Key executives
| Name | Title | Pay | Exercised | Year born |
|---|---|---|---|---|
| Mr. Andres Fajardo | Co-Founder, CEO & Director | 232.02k | N/A | 1978 |
| Mr. Henry R. Hague III | Chief Financial Officer | 311.02k | N/A | 1972 |
| Mr. Julian Wilches | Chief Regulatory Officer | 202.49k | N/A | 1979 |
| Mr. Gustavo Escobar | Chief Operating Officer | N/A | N/A | N/A |
| Ms. Marta Pinto Leite | Gen. Counsel & Corp. Sec. | N/A | N/A | N/A |
| Mr. Amit Pandey | Exec. VP of Fin. | N/A | N/A | 1982 |
| Mr. Andrew Miller | Head of Bus. Devel. | N/A | N/A | N/A |
| Mr. Camilo Bohorquez | Head of Colombia | N/A | N/A | N/A |
| Ms. Caroline Kliess | Managing Director of Germany | N/A | N/A | N/A |
| Jackie Keshner | Investor Relations Exec. | N/A | N/A | N/A |
Description
Clever Leaves Holdings Inc. operates in the botanical cannabinoid and nutraceutical industries. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment engages in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products internationally. The Non-Cannabinoid segment is engaged in formulating, manufacturing, marketing, selling, distributing, and commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. It also produces extracted products, including isolates, crude oil extracts, standardized extracts, and oral solutions, as well as tetrahydrocannabinol flower. The company was incorporated in 2017 and is based in Tocancipá, Colombia.
Corporate governance
Clever Leaves Holdings Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.
